US2844579A
(en)
|
|
1958-07-22 |
|
Process for thiamine monomtrate |
US3180859A
(en)
|
1962-12-05 |
1965-04-27 |
Upjohn Co |
Derivatives of decoyinine and process for preparing same
|
US3431252A
(en)
|
1966-04-01 |
1969-03-04 |
Merck & Co Inc |
5,5-dialkyl-d-ribofuranosyl purine compounds and intermediates
|
US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
GB1319303A
(en)
|
1970-07-14 |
1973-06-06 |
Univ Bradford |
Sugar derivatives
|
US3816399A
(en)
|
1970-07-14 |
1974-06-11 |
Univ Bradford |
1-amine nucleosides
|
US3872098A
(en)
|
1972-10-10 |
1975-03-18 |
Syntex Inc |
1,n{hu 6{b ethenoadenosine cyclophosphate compounds
|
US3872084A
(en)
|
1972-10-10 |
1975-03-18 |
Syntex Inc |
Purine nucleoside 3,5-cyclicphosphate compounds
|
US4093714A
(en)
|
1974-03-15 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
9β-D-Arabinofuranosylpurine nucleotides and method of use
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
NL8420134A
(nl)
|
1983-05-24 |
1985-04-01 |
Stanford Res Inst Int |
Nieuwe antivirusmiddelen.
|
PL144471B1
(en)
|
1985-04-22 |
1988-05-31 |
Polska Akad Nauk Centrum |
Method of obtaining novel 3',5'-cyclic adensine dithiophosphate
|
HU196607B
(en)
|
1985-05-15 |
1988-12-28 |
Wellcome Found |
Process for producing dideoxy-nucleosides and pharmaceutics comprising such compounds
|
JPH0446124Y2
(es)
|
1986-02-25 |
1992-10-29 |
|
|
WO1988003147A1
(en)
|
1986-10-31 |
1988-05-05 |
Warner-Lambert Company |
Selected n6-substituted adenosines having selective a2 binding activity
|
IL86007A0
(en)
|
1987-04-09 |
1988-09-30 |
Wellcome Found |
6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
|
US4885739A
(en)
|
1987-11-13 |
1989-12-05 |
Dsc Communications Corporation |
Interprocessor switching network
|
DE3824110A1
(de)
|
1988-07-15 |
1990-01-18 |
Max Planck Gesellschaft |
Verfahren zur herstellung und reinigung von an ihrem 5'-ende phosphorylierten oligo- und jpolynukleotidsequenzen und reagenz zur durchfuehrung des verfahrens
|
NO171507C
(no)
|
1988-11-21 |
1993-03-24 |
Syntex Inc |
Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
GB9009861D0
(en)
|
1990-05-02 |
1990-06-27 |
Glaxo Group Ltd |
Chemical compounds
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
US5677437A
(en)
|
1990-07-27 |
1997-10-14 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5378825A
(en)
|
1990-07-27 |
1995-01-03 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs
|
US6087482A
(en)
|
1990-07-27 |
2000-07-11 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
AU665184B2
(en)
|
1991-01-23 |
1995-12-21 |
Gensia, Inc. |
Adenosine kinase inhibitors
|
WO1992020816A1
(en)
|
1991-05-15 |
1992-11-26 |
Yale University |
Determination of prodrugs metabolizable by the liver and therapeutic use thereof
|
IT1249732B
(it)
|
1991-11-26 |
1995-03-09 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso.
|
US6469158B1
(en)
|
1992-05-14 |
2002-10-22 |
Ribozyme Pharmaceuticals, Incorporated |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5977343A
(en)
|
1992-05-14 |
1999-11-02 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5714383A
(en)
|
1992-05-14 |
1998-02-03 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for treating chronic myelogenous leukemia
|
US5686599A
(en)
|
1992-05-14 |
1997-11-11 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5804683A
(en)
|
1992-05-14 |
1998-09-08 |
Ribozyme Pharmaceuticals, Inc. |
Deprotection of RNA with alkylamine
|
US5625056A
(en)
|
1992-05-26 |
1997-04-29 |
Biolog Life Science Institute |
Derivatives of cyclic guanosine-3',5'-monophosphorothioate
|
US5721350A
(en)
|
1992-06-18 |
1998-02-24 |
Chattopadhyaya; Jyoti |
Deuterated nucleosides
|
US5811300A
(en)
|
1992-12-07 |
1998-09-22 |
Ribozyme Pharmaceuticals, Inc. |
TNF-α ribozymes
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
US5837542A
(en)
|
1992-12-07 |
1998-11-17 |
Ribozyme Pharmaceuticals, Inc. |
Intercellular adhesion molecule-1 (ICAM-1) ribozymes
|
US5616488A
(en)
|
1992-12-07 |
1997-04-01 |
Ribozyme Pharmaceuticals, Inc. |
IL-5 targeted ribozymes
|
JPH06228186A
(ja)
|
1993-01-29 |
1994-08-16 |
Yamasa Shoyu Co Ltd |
2’−デオキシ−(2’s)−アルキルピリミジンヌクレオシド誘導体
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
AU6551094A
(en)
|
1993-03-31 |
1994-10-24 |
Sterling Winthrop Inc. |
Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
|
EP0691979A1
(en)
|
1993-03-31 |
1996-01-17 |
Sanofi |
Novel 5'-substituted nucleosides and oligomers produced therefrom
|
GB9311682D0
(en)
|
1993-06-05 |
1993-07-21 |
Ciba Geigy Ag |
Chemical compounds
|
US6017896A
(en)
|
1993-09-14 |
2000-01-25 |
University Of Alabama Research Foundation And Southern Research Institute |
Purine nucleoside phosphorylase gene therapy for human malignancy
|
US5552311A
(en)
|
1993-09-14 |
1996-09-03 |
University Of Alabama At Birmingham Research Foundation |
Purine nucleoside phosphorylase gene therapy for human malignancy
|
US6491905B1
(en)
|
1993-09-14 |
2002-12-10 |
The Uab Research Foundation |
Recombinant bacterial cells for delivery of PNP to tumor cells
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
EP0725788B1
(en)
|
1993-10-27 |
1998-12-16 |
Ribozyme Pharmaceuticals, Inc. |
2'-amido and 2'-peptido modified oligonucleotides
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
AU1436995A
(en)
|
1993-12-30 |
1995-07-17 |
Chemgenes Corporation |
Synthesis of propargyl modified nucleosides and phosphoramidites and their incorporation into defined sequence oligonucleotides
|
US5693532A
(en)
|
1994-11-04 |
1997-12-02 |
Ribozyme Pharmaceuticals, Inc. |
Respiratory syncytial virus ribozymes
|
US5639647A
(en)
|
1994-03-29 |
1997-06-17 |
Ribozyme Pharmaceuticals, Inc. |
2'-deoxy-2'alkylnucleotide containing nucleic acid
|
US5631359A
(en)
|
1994-10-11 |
1997-05-20 |
Ribozyme Pharmaceuticals, Inc. |
Hairpin ribozymes
|
US5902880A
(en)
|
1994-08-19 |
1999-05-11 |
Ribozyme Pharmaceuticals, Inc. |
RNA polymerase III-based expression of therapeutic RNAs
|
US5620676A
(en)
|
1994-03-08 |
1997-04-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biologically active ATP analogs
|
US6639061B1
(en)
|
1999-07-07 |
2003-10-28 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate oligomers and related compounds
|
US5871918A
(en)
|
1996-06-20 |
1999-02-16 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
US6063566A
(en)
|
1994-05-13 |
2000-05-16 |
The Scripps Research Institute |
Catalytic RNA molecules
|
US5580967A
(en)
|
1994-05-13 |
1996-12-03 |
The Scripps Research Institute |
Optimized catalytic DNA-cleaving ribozymes
|
GB9417746D0
(en)
|
1994-09-03 |
1994-10-19 |
Ciba Geigy Ag |
Chemical compounds
|
GB9417938D0
(en)
|
1994-09-06 |
1994-10-26 |
Ciba Geigy Ag |
Compounds
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US7141665B1
(en)
|
1998-04-29 |
2006-11-28 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
EP0806956B1
(de)
|
1995-02-01 |
2002-08-28 |
RESprotect GmbH |
Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
WO1996030383A1
(de)
|
1995-03-24 |
1996-10-03 |
Christian Noe |
Nukleinsäure-polyester-polyamide
|
US5968745A
(en)
|
1995-06-27 |
1999-10-19 |
The University Of North Carolina At Chapel Hill |
Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof
|
US6361951B1
(en)
|
1995-06-27 |
2002-03-26 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
US6132971A
(en)
|
1995-06-27 |
2000-10-17 |
The University Of North Carolina At Chapel Hill |
Microelectronic device
|
US6004939A
(en)
|
1995-07-06 |
1999-12-21 |
Ctrc Research Foundation Board Of Regents |
Methods for modulation and inhibition of telomerase
|
US20010011075A1
(en)
|
1999-02-05 |
2001-08-02 |
Leroy B Townsend |
5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
|
EP1108724B1
(en)
|
1996-01-16 |
2007-09-19 |
Sirna Therpeutics, Inc. |
Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
|
US5767097A
(en)
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
EP0799834A1
(en)
|
1996-04-04 |
1997-10-08 |
Novartis AG |
Modified nucleotides
|
US20040171028A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20050042647A1
(en)
|
1996-06-06 |
2005-02-24 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20050032067A1
(en)
|
2002-11-05 |
2005-02-10 |
Prakash Thazha P. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20040171032A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
AU3340797A
(en)
|
1996-06-28 |
1998-01-21 |
Novartis Ag |
Modified oligonucleotides
|
NZ334915A
(en)
|
1996-10-16 |
2000-11-24 |
Icn Pharmaceuticals |
Monocyclic L-nucleosides, analogs thereof and their use in the modulation of Th1 and Th2 activities
|
NZ505531A
(en)
|
1996-10-16 |
2001-08-31 |
Icn Pharmaceuticals |
7-Propyl-8-oxo-alpha or beta-L-guanine alpha or beta-L-nucleoside
|
ZA979327B
(en)
|
1996-10-18 |
1998-05-11 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease.
|
US6887707B2
(en)
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
NZ335000A
(en)
|
1996-10-28 |
2000-12-22 |
Univ Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
US7078391B2
(en)
|
1997-02-10 |
2006-07-18 |
Inspire Pharmaceuticals, Inc. |
Method of treating edematous retinal disorders
|
US20030144489A1
(en)
|
1997-06-09 |
2003-07-31 |
Alex Burgin |
Method for screening nucleic acid catalysts
|
NZ503262A
(en)
|
1997-08-11 |
2002-10-25 |
Boehringer Ingelheim Ca Ltd |
Hepatitis C NS3 protease inhibitor peptides and peptide analogues
|
DE69827956T2
(de)
|
1997-08-11 |
2005-04-14 |
Boehringer Ingelheim (Canada) Ltd., Laval |
Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
|
WO1999010365A2
(en)
|
1997-08-29 |
1999-03-04 |
Gilead Sciences, Inc. |
5',5'-linked oligomers having anti-thrombin activity
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US6232463B1
(en)
|
1997-10-09 |
2001-05-15 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
US6703374B1
(en)
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
US6482932B1
(en)
|
1997-11-05 |
2002-11-19 |
Ribozyme Pharmaceuticals, Incorporated |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
US6528640B1
(en)
|
1997-11-05 |
2003-03-04 |
Ribozyme Pharmaceuticals, Incorporated |
Synthetic ribonucleic acids with RNAse activity
|
US6617438B1
(en)
|
1997-11-05 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Oligoribonucleotides with enzymatic activity
|
US20030004122A1
(en)
|
1997-11-05 |
2003-01-02 |
Leonid Beigelman |
Nucleotide triphosphates and their incorporation into oligonucleotides
|
US6015703A
(en)
|
1998-03-10 |
2000-01-18 |
Iogen Corporation |
Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
|
CA2330574A1
(en)
|
1998-04-29 |
1999-11-04 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into ribozymes
|
US6030957A
(en)
|
1998-06-29 |
2000-02-29 |
Wayne Hughes Institute |
Aryl phosphate derivatives of d4T having anti-HIV activity
|
US7091315B1
(en)
|
1998-07-15 |
2006-08-15 |
Human Genome Sciences, Inc. |
Protein HDPBQ71
|
US6492423B1
(en)
|
1998-07-27 |
2002-12-10 |
Istituto Di Ricerche Di Biologia Molecolare Pangeletti Spa |
Diketoacid-derivatives as inhibitors of polymerases
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
AR022061A1
(es)
|
1998-08-10 |
2002-09-04 |
Boehringer Ingelheim Ca Ltd |
Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
|
WO2000014263A2
(en)
|
1998-09-03 |
2000-03-16 |
Board Of Regents, The University Of Texas System |
Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
|
US6566059B1
(en)
|
1998-10-01 |
2003-05-20 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6458945B1
(en)
|
1998-10-01 |
2002-10-01 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6440705B1
(en)
|
1998-10-01 |
2002-08-27 |
Vincent P. Stanton, Jr. |
Method for analyzing polynucleotides
|
CA2252144A1
(en)
|
1998-10-16 |
2000-04-16 |
University Of Alberta |
Dual action anticancer prodrugs
|
JP2002540080A
(ja)
|
1999-03-19 |
2002-11-26 |
パーカー ヒューズ インスティテュート |
ゲルミクロ乳濁液製剤
|
US7064114B2
(en)
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
US6569630B1
(en)
|
1999-07-02 |
2003-05-27 |
Conceptual Mindworks, Inc. |
Methods and compositions for aptamers against anthrax
|
US20040023265A1
(en)
|
1999-07-02 |
2004-02-05 |
Jeevalatha Vivekananda |
Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin
|
WO2001009317A1
(fr)
|
1999-07-29 |
2001-02-08 |
Helix Research Institute |
Gene associe au cancer de l'estomac
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
MXPA02001753A
(es)
|
1999-08-27 |
2002-10-23 |
Ribapharm Inc |
Analogos de nucleosido de pirrolo [2,3-d]pirimidina.
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
IL145071A0
(en)
|
1999-12-27 |
2002-06-30 |
Japan Tobacco Inc |
Fused ring compounds and pharmaceutical compositions containing the same
|
US6649750B1
(en)
|
2000-01-05 |
2003-11-18 |
Isis Pharmaceuticals, Inc. |
Process for the preparation of oligonucleotide compounds
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
EP1296690A2
(en)
|
2000-02-18 |
2003-04-02 |
Shire Biochem Inc. |
METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES
|
US7235649B2
(en)
|
2000-03-24 |
2007-06-26 |
Duke University |
Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
|
JP2003528886A
(ja)
|
2000-03-24 |
2003-09-30 |
デューク・ユニバーシティ |
Crp94−リガンド相互作用の特徴付けおよびそれに関連する精製、スクリーニングおよび治療法
|
FR2808797A1
(fr)
|
2000-05-09 |
2001-11-16 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'uridine, leur procede de preparation et leur application comme medicaments
|
WO2001085172A1
(en)
|
2000-05-10 |
2001-11-15 |
Smithkline Beecham Corporation |
Novel anti-infectives
|
AU2001274888A1
(en)
|
2000-05-19 |
2001-12-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
CA2410488C
(en)
|
2000-05-26 |
2009-10-27 |
Idenix (Cayman) Limited |
Methods of treating hepatitis delta virus infection with .beta.-l-2' deoxy-nucleosides
|
AU2001265296A1
(en)
|
2000-05-26 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
AU2001272923A1
(en)
|
2000-05-26 |
2001-12-11 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
US6974667B2
(en)
|
2000-06-14 |
2005-12-13 |
Gene Logic, Inc. |
Gene expression profiles in liver cancer
|
ES2609016T3
(es)
|
2000-06-16 |
2017-04-18 |
Human Genome Sciences, Inc. |
Anticuerpos que se unen inmunoespecíficamente a BLyS
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
US20030207271A1
(en)
|
2000-06-30 |
2003-11-06 |
Holwitt Eric A. |
Methods and compositions for biological sensors
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
US20030166064A1
(en)
|
2000-08-03 |
2003-09-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
EP1346040A2
(en)
|
2000-09-11 |
2003-09-24 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
WO2002026930A2
(en)
|
2000-09-26 |
2002-04-04 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
CN1133642C
(zh)
|
2000-10-09 |
2004-01-07 |
清华大学 |
核苷5’-硫代磷酰氨基酸酯化合物
|
NZ561342A
(en)
|
2000-10-18 |
2010-02-26 |
Pharmasset Inc |
Simultaneous quantification of nucleic acids in diseased cells
|
US20020150922A1
(en)
|
2000-11-20 |
2002-10-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
WO2002060926A2
(en)
|
2000-11-20 |
2002-08-08 |
Bristol-Myers Squibb Company |
Hepatitis c tripeptide inhibitors
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
CA2434386C
(en)
|
2001-01-22 |
2006-12-05 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
US20030073144A1
(en)
|
2001-01-30 |
2003-04-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of pancreatic cancer
|
AU2002252183A1
(en)
|
2001-03-06 |
2002-09-19 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
CA2441397A1
(en)
|
2001-03-21 |
2002-10-03 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
WO2002079449A2
(en)
|
2001-03-28 |
2002-10-10 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
US6995148B2
(en)
|
2001-04-05 |
2006-02-07 |
University Of Pittsburgh |
Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
|
CN1186456C
(zh)
|
2001-04-30 |
2005-01-26 |
曹卫 |
通用模板核酸检测方法和试剂盒
|
EP1256628A3
(en)
|
2001-05-10 |
2003-03-19 |
Agouron Pharmaceuticals, Inc. |
Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
|
GB2392157B
(en)
|
2001-05-16 |
2005-12-21 |
Micrologix Biotech Inc |
Nucleic acid-based compounds and methods of use thereof
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
EP1390385A4
(en)
|
2001-05-29 |
2004-11-24 |
Sirna Therapeutics Inc |
MODULATION OF DISEASES AND DISEASES OF THE FEMALE REPRODUCTION SYSTEM BASED ON NUCLEIC ACID
|
AR036081A1
(es)
|
2001-06-07 |
2004-08-11 |
Smithkline Beecham Corp |
Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
|
SK288015B6
(sk)
|
2001-06-11 |
2012-11-05 |
Virochem Pharma Inc. |
Thiophene derivatives as antiviral agents for flavivirus infection
|
CA2449999C
(en)
|
2001-06-11 |
2012-07-31 |
Shire Biochem Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
EP1478772A2
(en)
|
2001-08-14 |
2004-11-24 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
WO2003016572A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Oligonucleotide therapeutics for treating hepatitis c virus infections
|
WO2003016497A2
(en)
|
2001-08-17 |
2003-02-27 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
CN1159332C
(zh)
|
2001-08-24 |
2004-07-28 |
清华大学 |
一种硫代磷酰氨基酸酯化合物及其制备方法
|
CN1133641C
(zh)
|
2001-08-24 |
2004-01-07 |
清华大学 |
一种含有3'叠氮胸苷的硫代磷酰氨基酸酯化合物及其制备方法
|
CN1186457C
(zh)
|
2001-08-29 |
2005-01-26 |
曹卫 |
均相基因矩阵
|
AU2002343417A1
(en)
|
2001-09-24 |
2003-04-14 |
Nuvelo |
Novel nucleic acids and polypeptides
|
US20030134853A1
(en)
|
2001-09-26 |
2003-07-17 |
Priestley Eldon Scott |
Compounds useful for treating hepatitis C virus
|
EP1434860A2
(en)
|
2001-09-28 |
2004-07-07 |
Incyte Genomics, Inc. |
Enzymes
|
WO2003031419A1
(en)
|
2001-10-09 |
2003-04-17 |
3-Dimensional Pharmaceuticals, Inc. |
Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
|
JP2005518191A
(ja)
|
2001-10-19 |
2005-06-23 |
インサイト・ゲノミックス・インコーポレイテッド |
キナーゼ及びホスファターゼ
|
EP1441720B8
(en)
|
2001-10-24 |
2012-03-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system
|
US7488598B2
(en)
|
2001-10-26 |
2009-02-10 |
Cornell Center For Technology Enterprise And Commercialization |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
US7037718B2
(en)
|
2001-10-26 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
JP2005508636A
(ja)
|
2001-10-29 |
2005-04-07 |
インサイト・ゲノミックス・インコーポレイテッド |
核酸結合タンパク質
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
AU2002350174A1
(en)
|
2001-11-09 |
2003-05-19 |
Incyte Genomics Inc. |
Intracellular signaling molecules
|
EP1504099A4
(en)
|
2001-12-10 |
2006-05-10 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
WO2003051896A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies
|
AU2002358273A1
(en)
|
2001-12-19 |
2003-07-09 |
Incyte Corporation |
Nucleic acid-associated proteins
|
AU2002367554A1
(en)
|
2001-12-20 |
2003-09-09 |
Cellzome Ag |
Protein complexes and methods for their use
|
AU2003210518A1
(en)
|
2002-01-16 |
2003-09-02 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
US20070032448A1
(en)
|
2002-01-17 |
2007-02-08 |
Zhi Hong |
Sugar modified nucleosides as viral replication inhibitors
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
AU2003205174A1
(en)
|
2002-01-17 |
2003-09-02 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
WO2003062391A2
(en)
|
2002-01-18 |
2003-07-31 |
Incyte Corporation |
Structural and cytoskeleton-associated proteins
|
WO2003063688A2
(en)
|
2002-01-25 |
2003-08-07 |
Incyte Corporation |
Protein modification and maintenance molecules
|
US20050042632A1
(en)
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US20080207542A1
(en)
|
2002-03-26 |
2008-08-28 |
Sirna Therapeutics, Inc. |
RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
|
AU2003216376A1
(en)
|
2002-02-22 |
2003-09-09 |
Incyte Corporation |
Enzymes
|
EP1485395A4
(en)
|
2002-02-28 |
2011-04-13 |
Biota Scient Management |
NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF
|
US7112406B2
(en)
|
2002-03-01 |
2006-09-26 |
Integrated Dna Technologies, Inc. |
Polynomial amplification of nucleic acids
|
AU2003217992A1
(en)
|
2002-03-06 |
2003-09-22 |
Incyte Corporation |
Nucleic acid-associated proteins
|
AU2003218238A1
(en)
|
2002-03-15 |
2003-09-29 |
Incyte Corporation |
Proteins associated with growth, differentiation, and death
|
AU2003224811A1
(en)
|
2002-03-28 |
2003-10-13 |
Incyte Corporation |
Transporters and ion channels
|
WO2003083082A2
(en)
|
2002-03-29 |
2003-10-09 |
Incyte Corporation |
Enzymes
|
AU2003231981A1
(en)
|
2002-03-29 |
2003-10-13 |
Incyte Corporation |
Protein modification and maintenance molecules
|
WO2003087300A2
(en)
|
2002-04-05 |
2003-10-23 |
Incyte Corporation |
Secreted proteins
|
US20030190626A1
(en)
|
2002-04-09 |
2003-10-09 |
Vasulinga Ravikumar |
Phosphorothioate monoester modified oligomers
|
AU2003223602B8
(en)
|
2002-04-11 |
2010-05-27 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis C virus NS3-NS4 protease
|
US20060074035A1
(en)
*
|
2002-04-17 |
2006-04-06 |
Zhi Hong |
Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections
|
US20050288258A1
(en)
|
2002-04-23 |
2005-12-29 |
Diana Guy D |
Compounds, compositions and methods for treating or preventing viral infections and associated diseases
|
AU2003225282A1
(en)
|
2002-04-29 |
2003-11-17 |
Incyte Corporation |
Enzymes
|
MXPA04010983A
(es)
|
2002-05-06 |
2005-02-14 |
Genelabs Tech Inc |
Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
|
WO2003094848A2
(en)
|
2002-05-10 |
2003-11-20 |
Incyte Corporation |
Nucleic acid-associated proteins
|
FR2840318B1
(fr)
|
2002-05-29 |
2004-12-03 |
Quoc Kiet Pham |
Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
|
US7906491B2
(en)
|
2002-06-07 |
2011-03-15 |
Univisitair Medisch Centrum Utrecht |
Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)
|
AU2003245627A1
(en)
|
2002-06-21 |
2004-01-06 |
Incyte Corporation |
Kinases and phosphatases
|
US7662798B2
(en)
|
2002-06-28 |
2010-02-16 |
Idenix Pharmaceuticals, Inc. |
2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
WO2004003162A2
(en)
|
2002-06-28 |
2004-01-08 |
Incyte Corporation |
Enzymes
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
RS114104A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited, |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
AU2003268023A1
(en)
|
2002-07-23 |
2004-02-09 |
Incyte Corporation |
Protein modification and maintenance molecules
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
US7183302B2
(en)
|
2002-08-12 |
2007-02-27 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of HCV replication
|
GB0221694D0
(en)
|
2002-09-18 |
2002-10-30 |
Glaxo Group Ltd |
Compounds
|
AU2003278904A1
(en)
|
2002-09-24 |
2004-04-19 |
Kornis Pharmaceuticals, Incorporated |
1, 3, 5-triazines for treatment of viral diseases
|
US20070207973A1
(en)
|
2002-09-24 |
2007-09-06 |
Koronis Pharmaceuticals, Incorporated |
1,3,5-Triazines for Treatment of Viral Diseases
|
US7094768B2
(en)
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
JP2006519753A
(ja)
|
2002-11-15 |
2006-08-31 |
イデニクス(ケイマン)リミテツド |
2’−分枝ヌクレオシドおよびフラビウイルス科ウイルス突然変異
|
US20050037394A1
(en)
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
WO2004050899A2
(en)
|
2002-12-03 |
2004-06-17 |
Archemix Corporation |
Method for in vitro selection of 2’-substituted nucleic acids
|
ES2470771T3
(es)
|
2002-12-12 |
2014-06-24 |
Idenix Pharmaceuticals, Inc |
Procedimiento para la producción de nucle�sidos ramificados en 2'
|
ES2381309T3
(es)
|
2002-12-23 |
2012-05-25 |
Dynavax Technologies Corporation |
Secuencia de oligonucleótidos inmunoestimuladores y métodos para usar los mismos
|
AR043006A1
(es)
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
WO2004080466A1
(en)
|
2003-03-07 |
2004-09-23 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
CA2521678A1
(en)
|
2003-04-11 |
2004-10-28 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
TW200510391A
(en)
|
2003-04-11 |
2005-03-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
US20090247488A1
(en)
|
2003-04-25 |
2009-10-01 |
Carina Cannizzaro |
Anti-inflammatory phosphonate compounds
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
PT1628685E
(pt)
|
2003-04-25 |
2011-03-16 |
Gilead Sciences Inc |
Análogos de fosfonatos antivirais
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
UA82695C2
(uk)
|
2003-06-06 |
2008-05-12 |
Нисан Кемикал Индастриз, Лтд. |
Гетероароматичні сполуки як активатори рецептора тромбопоетину
|
US20070203083A1
(en)
|
2003-06-13 |
2007-08-30 |
Mootha Vamsi K |
Methods Of Regulating Metabolism And Mitochondrial Function
|
WO2005005658A1
(en)
|
2003-07-14 |
2005-01-20 |
Capitalbio Corporation |
Methods and compositions for detecting sars virus and other infectious agents
|
US7109172B2
(en)
|
2003-07-18 |
2006-09-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
EP1660511B1
(en)
|
2003-08-27 |
2010-11-03 |
Biota Scientific Management Pty. Ltd. |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
UY28500A1
(es)
|
2003-09-05 |
2005-04-29 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
|
EP1664091A1
(en)
|
2003-09-18 |
2006-06-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
JP2007509180A
(ja)
|
2003-10-21 |
2007-04-12 |
インスパイアー ファーマシューティカルズ,インコーポレイティド |
疼痛を治療するための、非ヌクレオチド組成物および方法
|
US7749981B2
(en)
|
2003-10-21 |
2010-07-06 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
|
US7335648B2
(en)
|
2003-10-21 |
2008-02-26 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide composition and method for inhibiting platelet aggregation
|
US7504497B2
(en)
|
2003-10-21 |
2009-03-17 |
Inspire Pharmaceuticals, Inc. |
Orally bioavailable compounds and methods for inhibiting platelet aggregation
|
US7144868B2
(en)
|
2003-10-27 |
2006-12-05 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
DE602004027409D1
(de)
|
2003-10-21 |
2010-07-08 |
Inspire Pharmaceuticals Inc |
Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
JP2005162732A
(ja)
|
2003-11-13 |
2005-06-23 |
Bayer Cropscience Ag |
殺虫性ニコチノイルカーバメート類
|
US20070238099A1
(en)
|
2003-12-08 |
2007-10-11 |
Cohen Irun R |
Antigen Receptor Variable Region Typing
|
CA2554999A1
(en)
|
2004-02-04 |
2005-08-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
US20070276139A1
(en)
|
2004-02-10 |
2007-11-29 |
Quanlai Song |
Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis
|
CA2555390C
(en)
|
2004-02-19 |
2014-08-05 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
US8759317B2
(en)
|
2004-03-18 |
2014-06-24 |
University Of South Florida |
Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)
|
EP2399924B1
(en)
|
2004-05-27 |
2015-01-28 |
Alnylam Pharmaceuticals, Inc. |
Nuclease resistant double-stranded ribonucleic acid
|
GB0413726D0
(en)
|
2004-06-18 |
2004-07-21 |
Lauras As |
Compounds
|
EP1789553B1
(en)
|
2004-06-30 |
2014-03-26 |
Alnylam Pharmaceuticals Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
BRPI0511834A
(pt)
|
2004-07-14 |
2008-01-08 |
Ptc Therapeutics Inc |
métodos por tratar hepatite c
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
CN101044151B
(zh)
|
2004-08-23 |
2011-01-19 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-叠氮基-核苷
|
EP2305693B1
(en)
|
2004-09-01 |
2015-07-15 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of innate immune responses and autoimmunity
|
PT3109244T
(pt)
|
2004-09-14 |
2019-06-04 |
Gilead Pharmasset Llc |
¿preparação de ribofuranosil pirimidinas e purinas 2¿-fluoro-2¿-alquil substituídas ou outras opcionalmente substituídas e os seus derivados
|
US7553653B2
(en)
|
2004-09-17 |
2009-06-30 |
Biomarin Pharmaceutical Inc. |
Variants and chemically-modified variants of phenylalanine ammonia-lyase
|
NZ572403A
(en)
|
2004-09-24 |
2010-03-26 |
Alnylam Pharmaceuticals Inc |
Rnai modulation of apob and uses thereof
|
WO2006038865A1
(en)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
|
MX2007003812A
(es)
|
2004-10-01 |
2007-05-24 |
Vertex Pharma |
Inhibicion de proteasa ns3-ns4a del virus de la hepatitis c (vhc).
|
RU2395505C2
(ru)
|
2004-12-08 |
2010-07-27 |
Ниссан Кемикал Индастриз, ЛТД |
3-этилиденгидразино-замещенные гетероциклические соединения в качестве активаторов рецептора тромбопоэтина
|
CA2589406A1
(en)
|
2004-12-09 |
2006-06-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas
|
ES2525567T3
(es)
|
2004-12-17 |
2014-12-26 |
Anadys Pharmaceuticals, Inc. |
Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos
|
EP1836218A2
(en)
|
2004-12-17 |
2007-09-26 |
Dynavax Technologies Corporation |
Methods and compositions for induction or promotion of immune tolerance
|
US20070066552A1
(en)
|
2005-01-21 |
2007-03-22 |
Introgen Therapeutics, Inc. |
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
|
WO2006096769A2
(en)
|
2005-03-08 |
2006-09-14 |
Intermune, Inc. |
Use of alpha-glucosidase inhibitors to treat alphavirus infections
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
JP2006248949A
(ja)
|
2005-03-09 |
2006-09-21 |
Univ Nagoya |
ヌクレオシド誘導体、ヌクレオチド誘導体及びそれらの製造方法
|
JP2006248975A
(ja)
|
2005-03-10 |
2006-09-21 |
Tokyo Institute Of Technology |
ヌクレオシドホスホロアミダイト化合物
|
EP1877054A2
(en)
|
2005-03-30 |
2008-01-16 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
ES2261072B1
(es)
|
2005-04-06 |
2007-12-16 |
Consejo Superior Investig. Cientificas |
Fosforotioatos derivados de analogos a nucleosido para terapia antirretroviral.
|
US20060240462A1
(en)
|
2005-04-21 |
2006-10-26 |
Johnson & Johnson Research Pty Limited |
Methods for amplification and detection of nucleic acids
|
WO2006116512A1
(en)
|
2005-04-26 |
2006-11-02 |
The Board Of Trustees Of The University Of Illinois, Urbana, Il |
Nucleoside compounds and methods of use thereof
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
US7953557B2
(en)
|
2005-06-01 |
2011-05-31 |
The Scripps Research Institute |
Crystal of a cytochrome-ligand complex and methods of use
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
WO2007006544A2
(en)
|
2005-07-12 |
2007-01-18 |
Vrije Universiteit Brussel |
Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
|
WO2007015757A2
(en)
|
2005-07-21 |
2007-02-08 |
Nereus Pharmaceuticals, Inc. |
Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
WO2007020193A2
(en)
|
2005-08-15 |
2007-02-22 |
F. Hoffmann-La Roche Ag |
Antiviral phosphoramidates of 4 ' -substituted pronucleotides
|
CA2620223A1
(en)
|
2005-09-02 |
2007-03-08 |
Abbott Laboratories |
Novel imidazo based heterocycles
|
WO2007041774A1
(en)
|
2005-10-07 |
2007-04-19 |
Johnson & Johnson Research Pty Limited |
Multicomponent nucleic acid enzymes and methods for their use
|
WO2007051303A1
(en)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
CA2626584A1
(en)
|
2005-11-04 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of nav1.8 gene
|
EP1974732A4
(en)
|
2005-11-24 |
2010-08-11 |
Univ Hokkaido Nat Univ Corp |
THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
|
WO2007065829A1
(en)
|
2005-12-09 |
2007-06-14 |
F. Hoffmann-La Roche Ag |
Antiviral nucleosides
|
US20090221684A1
(en)
|
2005-12-22 |
2009-09-03 |
Trustees Of Boston University |
Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof
|
JP2009524828A
(ja)
|
2006-01-27 |
2009-07-02 |
ジョージ メーソン ユニバーシティー |
眼の流体のマーカー
|
EP1993611A4
(en)
|
2006-03-16 |
2013-05-22 |
Alnylam Pharmaceuticals Inc |
RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES
|
EP2008274B1
(en)
|
2006-03-31 |
2015-05-27 |
Alnylam Pharmaceuticals Inc. |
Compositions and methods for inhibiting expression of eg5 gene
|
FR2900334B1
(fr)
|
2006-04-28 |
2008-06-27 |
Oreal |
Procede de depigmentation de la peau
|
WO2007130783A2
(en)
|
2006-05-03 |
2007-11-15 |
Chimerix, Inc. |
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
|
WO2007149554A2
(en)
|
2006-06-22 |
2007-12-27 |
The Johns Hopkins University |
Methods for restoring neural function
|
US8470522B2
(en)
|
2006-07-20 |
2013-06-25 |
Kaohsiung Medical University |
Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the same
|
WO2008039267A2
(en)
|
2006-07-21 |
2008-04-03 |
Pharmexa Inc. |
Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7678803B2
(en)
|
2006-08-24 |
2010-03-16 |
Serenex, Inc. |
Quinazoline derivatives for the treatment of cancer
|
CA2661873A1
(en)
|
2006-08-31 |
2008-03-06 |
Abbott Laboratories |
Cytochrome p450 oxidase inhibitors and uses thereof
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
WO2008033466A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
GB0618235D0
(en)
|
2006-09-15 |
2006-10-25 |
Lauras As |
Process
|
CN101573370B
(zh)
|
2006-10-10 |
2013-09-11 |
美迪维尔公司 |
Hcv核苷类抑制剂
|
PL216525B1
(pl)
|
2006-10-17 |
2014-04-30 |
Ct Badań Molekularnych I Makromolekularnych Polskiej Akademii Nauk |
5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
PL2094849T3
(pl)
|
2006-11-09 |
2014-06-30 |
Dynavax Tech Corp |
Długotrwała zmiana przebiegu choroby z zastosowaniem oligonukleotydów immunostymulujących
|
US7598040B2
(en)
|
2006-11-22 |
2009-10-06 |
Trana Discovery, Inc. |
Compositions and methods for the identification of inhibitors of protein synthesis
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
AU2007342367B2
(en)
|
2007-01-05 |
2012-12-06 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
CA2676822A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
EP2125852B1
(en)
|
2007-02-15 |
2016-04-06 |
Ionis Pharmaceuticals, Inc. |
5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
|
AU2008219165A1
(en)
|
2007-02-16 |
2008-08-28 |
Merck Sharp & Dohme Corp. |
Compositions and methods for potentiated activity of biologicaly active molecules
|
US8242087B2
(en)
|
2007-02-27 |
2012-08-14 |
K.U.Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
US20120108533A1
(en)
|
2007-02-27 |
2012-05-03 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
WO2008104408A2
(en)
|
2007-02-27 |
2008-09-04 |
K. U. Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
AU2008222523A1
(en)
|
2007-03-07 |
2008-09-12 |
Nventa Biopharmaceuticals Corporation |
Double-stranded locked nucleic acid compositions
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
GB0709791D0
(en)
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
PL211703B1
(pl)
|
2007-07-03 |
2012-06-29 |
Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk |
Tiohypofosforanowe i ditiohypofosforanowe analogi 5'-O-hypofosforanów nukleozydów i ich estry alkilowe oraz sposób ich wytwarzania
|
CN101108870A
(zh)
|
2007-08-03 |
2008-01-23 |
冷一欣 |
核苷磷酸酯类化合物及制备方法和应用
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
US20100305060A1
(en)
|
2007-11-29 |
2010-12-02 |
Ligand Pharmaceuticals Incorporated |
Nucleoside Prodrugs and Uses Thereof
|
WO2009086192A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
|
US20090181921A1
(en)
|
2007-12-21 |
2009-07-16 |
Alios Biopharma Inc. |
2-5a analogs and their methods of use
|
NZ587323A
(en)
|
2008-02-12 |
2012-02-24 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
PL2242752T3
(pl)
|
2008-02-13 |
2012-12-31 |
Bristol Myers Squibb Co |
Imidazolilobifenyloimidazole jako inhibitory wirusa zapalenia wątroby typu c
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CN102123716B
(zh)
|
2008-04-03 |
2013-09-18 |
春堤公司 |
用于治疗病毒感染的化合物和方法
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
ES2609685T7
(es)
|
2008-08-15 |
2019-05-22 |
Uab Res Found |
Purina nucleósido fosforilasa como activador enzimático de profármacos de nucleósidos
|
GB0815315D0
(en)
|
2008-08-21 |
2008-09-24 |
Univ Leiden |
Organ protection
|
WO2010030858A1
(en)
|
2008-09-15 |
2010-03-18 |
Enanta Pharmaceuticals, Inc. |
4'-allene-substituted nucleoside derivatives
|
EP2358397B1
(en)
|
2008-10-24 |
2020-01-01 |
Ionis Pharmaceuticals, Inc. |
5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
DK2373172T3
(da)
|
2008-12-03 |
2013-10-21 |
Presidio Pharmaceuticals Inc |
Hcv-ns5a-hæmmere
|
US9120779B2
(en)
|
2008-12-03 |
2015-09-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
EP2393815A4
(en)
|
2009-02-06 |
2012-11-21 |
Rfs Pharma Llc |
PURIN NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR THE TREATMENT OF CANCER AND VIRUS INFECTIONS
|
WO2010091413A1
(en)
|
2009-02-09 |
2010-08-12 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
US20120040977A1
(en)
|
2009-02-23 |
2012-02-16 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
CA2753382C
(en)
|
2009-02-27 |
2014-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
KR20110128947A
(ko)
|
2009-03-20 |
2011-11-30 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오시드 및 뉴클레오티드 유사체
|
RS54713B1
(en)
|
2009-03-27 |
2016-08-31 |
Merck Sharp & Dohme Corp. |
HEPATITIS VIRUS REPLICATION INHIBITORS C
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
RU2541571C2
(ru)
|
2009-04-15 |
2015-02-20 |
Эббви Инк. |
Противовирусные соединения
|
US8436036B2
(en)
|
2009-04-24 |
2013-05-07 |
Janssen R&D Ireland |
Diaryl ethers
|
EA201101568A1
(ru)
|
2009-04-28 |
2012-05-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta
|
AU2010249080A1
(en)
|
2009-05-12 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
US20100297079A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
MX2012008652A
(es)
|
2010-01-29 |
2012-08-23 |
Vertex Pharma |
Terapias para tratar infeccion por virus de hepatitis c.
|
AR084393A1
(es)
|
2010-06-10 |
2013-05-15 |
Gilead Sciences Inc |
Metodos para tratar el virus de la hepatitis c, composicion, uso, combinacion, kit y uno o mas compuestos anti vhc
|
CN103298475A
(zh)
*
|
2010-08-30 |
2013-09-11 |
斯普林银行医药公司 |
作为治疗剂的寡核苷酸类似物的设计
|
EP2619215B1
(en)
|
2010-09-22 |
2018-09-05 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
NZ607996A
(en)
*
|
2010-09-22 |
2014-07-25 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
WO2012088155A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
EP2696681B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
BR112014014740B1
(pt)
|
2011-12-22 |
2021-08-24 |
Alios Biopharma, Inc |
Compostos de nucleosídeos, nucleotídeos e análogos destes, seu uso e composição farmacêutica
|
EP2794630A4
(en)
*
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
EP2828278A4
(en)
|
2012-03-21 |
2015-12-09 |
Alios Biopharma Inc |
PROCESSES FOR PREPARING SUBSTITUTED NUCLEOTIDE ANALOGS
|
WO2013142124A1
(en)
*
|
2012-03-21 |
2013-09-26 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
CN104203253A
(zh)
|
2012-03-21 |
2014-12-10 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
EP2935305A4
(en)
|
2012-12-21 |
2016-08-03 |
Alios Biopharma Inc |
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGUE THEREOF
|
CA2894542C
(en)
|
2012-12-21 |
2023-10-31 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|